Cited by 2,780interferon and immune responsesImmune Response and InflammationCytokine Signaling Pathways and Interactions

The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.

Type I interferons in infectious disease

Open access

McNab, Finlay, Mayer-Barber, Katrin, Sher, Alan, Wack, Andreas, O'Garra, Anne·2015·Nature Reviews Immunology

DOI 10.1038/nri3787PMC PMC7162685

Open this paper in CoChat — free account Open PDF

Abstract

Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri3787

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citation
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829

Show all 238 references

Sorted by citations

Items 401–500 of 1,004

Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction
Sakamoto, K., Jin, S., Goel, S., Jo, J., Voisin, B., ‍Kim, D. Y., Nadella, V., Liang, H., Kobayashi, T., Huang, X., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.001 · Cited by 62
ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis
Anes, E., Pires, D., Mandal, M., & Azevedo‐Pereira, J. M. (2023) · Biomolecules · doi:10.3390/biom13060968 · Cited by 67
Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
Cruickshank, B. M., Giacomantonio, M., Marcato, P., McFarland, S. A., Pol, J. G., & Gujar, S. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00654 · Cited by 62
Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway
Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03166-9 · Cited by 60
Roles of long non-coding RNAs and emerging RNA-binding proteins in innate antiviral responses
Wang, Y., Wang, Y., Luo, W., Song, X., Huang, L., Xiao, J., Jin, F., Ren, Z., & Wang, Y. (2020) · Theranostics · doi:10.7150/thno.48520 · Cited by 61
The complex role of AIM2 in autoimmune diseases and cancers
Zhu, H., Zhao, M., Chang, C. C.-C., Chan, V. S. F., Lu, Q., & Wu, H. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.443 · Cited by 61
SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1
Jiao, P., Fan, W., Ma, X., Lin, R., Zhao, Y., Li, Y., Zhang, H., Jia, X., Bi, Y., Feng, X., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2238579 · Cited by 60
Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage
Bhattacharya, A., Hegazy, A. N., Deigendesch, N., Kosack, L., Cupovic, J., Kandasamy, R. K., Hildebrandt, A., Merkler, D., Kühl, A. A., Vilagos, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.013 · Cited by 60
A type I IFN-dependent DNA damage response regulates the genetic program and inflammasome activation in macrophages
Morales, A. J., Carrero, J. A., Hung, P. J., Tubbs, A., Andrews, J. M., Edelson, B. T., Calderón, B., Innes, C. L., Paules, R. S., Payton, J. E., et al. (2017) · eLife · doi:10.7554/elife.24655 · Cited by 62
Direct Antimicrobial Activity of IFN-β
Kaplan, A. T., Lee, M. W., Wolf, A. J., Limon, J. J., Becker, C. A., Ding, M., Murali, R., Lee, E. Y., Liu, G. Y., Wong, G. C. L., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601226 · Cited by 62
Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application
Roselli, F., Chandrasekar, A., & Morganti-Kossmann, M. C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00458 · Cited by 60
ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer
Somerville, T. D. D., Xu, Y., Wu, X., Maia-Silva, D., Hur, S. K., de Almeida, L. M. N., Preall, J. B., Koo, P. K., & Vakoc, C. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921484117 · Cited by 60
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 63
IFNA2: The prototypic human alpha interferon
Paul, F., Pellegrini, S., & Uzé, G. (2015) · Gene · doi:10.1016/j.gene.2015.04.087 · Cited by 69
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
Almendro-Vázquez, P., Laguna‐Goya, R., Ruiz‐Ruigómez, M., Utrero‐Rico, A., Lalueza, A., de la Calle, G. M., Delgado, P., Ordoño, L. P., Muro, E., Vila, J. J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010211 · Cited by 60
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Chi, X., Luo, S., Ye, P., Hwang, W., Cha, J., Yan, X., & Yang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104771 · Cited by 62
STING signaling in tumorigenesis and cancer therapy: A friend or foe?
He, L., Xiao, X., Yang, X., Zhang, Z., Wu, L., & Liu, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.026 · Cited by 62
Gut microbiota modulates type I interferon and antibody-mediated immune responses in chickens infected with influenza virus subtype H9N2
Yitbarek, A., Alkie, T. N., Taha-Abdelaziz, K., Astill, J., Rodriguez-Lecompte, J. C., Parkinson, J., Nagy, É., & Sharif, S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0088 · Cited by 61
An Update on Autoinflammatory Diseases: Interferonopathies
Davidson, S., Steiner, A., Harapas, C. R., & Masters, S. L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0748-y · Cited by 59
BK Polyomavirus Evades Innate Immune Sensing by Disrupting the Mitochondrial Network and Promotes Mitophagy
Manzetti, J., Weissbach, F. H., Graf, F. E., Unterstab, G., Wernli, M., Hopfer, H., Drachenberg, C. B., Rinaldo, C. H., & Hirsch, H. H. (2020) · iScience · doi:10.1016/j.isci.2020.101257 · Cited by 61
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
Ricci, D., Etna, M. P., Rizzo, F., Sandini, S., Severa, M., & Coccia, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137017 · Cited by 61
Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
Bessière, P., Wasniewski, M., Meyer, E. P., Servat, A., Figueroa, T., Foret, C., Coggon, A., Lesellier, S., Boué, F., Cebron, N., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009427 · Cited by 64
Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
Camacho, V., Kuznetsova, V., & Welner, R. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772408 · Cited by 60
Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis
Chen, L., Zhang, G., Li, G., Wang, W., Ge, Z., Yang, Y., He, X., Liu, Z., Zhang, Z., Mai, Q., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00547-3 · Cited by 60
JC Polyomavirus Infection of Primary Human Renal Epithelial Cells Is Controlled by a Type I IFN-Induced Response
Assetta, B., Cecco, M. D., O’Hara, B. A., & Atwood, W. J. (2016) · mBio · doi:10.1128/mbio.00903-16 · Cited by 58
Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening
Willemsen, J., Wicht, O., Wolanski, J., Baur, N., Bastian, S., Haas, D. A., Matula, P., Knapp, B. L., Meyniel‐Schicklin, L., Wang, C., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.021 · Cited by 57
Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology
Pott, J., & Stockinger, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00258 · Cited by 60
Distinct Effects of Type I and III Interferons on Enteric Viruses
Ingle, H., Peterson, S. T., & Baldridge, M. T. (2018) · Viruses · doi:10.3390/v10010046 · Cited by 59
Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation
Wallrapp, A., Riesenfeld, S. J., Burkett, P. R., & Kuchroo, V. K. (2018) · Immunological Reviews · doi:10.1111/imr.12702 · Cited by 57
Plant NLR immunity activation and execution: a biochemical perspective
Locci, F., & Parker, J. E. (2024) · Open Biology · doi:10.1098/rsob.230387 · Cited by 58
Protozoan Parasites and Type I IFNs
Silva‐Barrios, S., & Stäger, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00014 · Cited by 57
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment
Newby, B. N., & Mathews, C. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00232 · Cited by 57
SCD2-mediated monounsaturated fatty acid metabolism regulates cGAS-STING-dependent type I IFN responses in CD4+ T cells
Kanno, T., Nakajima, T., Yokoyama, S., Asou, H. K., Sasamoto, S., Kamii, Y., Hayashizaki, K., Ouchi, Y., Onodera, T., Takahashi, Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02310-y · Cited by 58
African Swine Fever Virus CD2v Protein Induces β-Interferon Expression and Apoptosis in Swine Peripheral Blood Mononuclear Cells
Chaulagain, S., Delhon, G. A., Khatiwada, S., & Rock, D. L. (2021) · Viruses · doi:10.3390/v13081480 · Cited by 57
The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation
Bai, X., Sui, C., Liu, F., Chen, T., Zhang, L., Zheng, Y., Liu, B., & Gao, C. (2022) · Nature Communications · doi:10.1038/s41467-022-32628-y · Cited by 56
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review
Felten, R., Scherlinger, M., Mertz, P., Chasset, F., & Arnaud, L. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105523 · Cited by 56
Regulation of immunogenic cell death and potential applications in cancer therapy
Fang, K., Yuan, S., Zhang, X., Zhang, J., Sun, S., & Li, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571212 · Cited by 58
Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response
Ma, L., Wang, H., Wu, P., Hu, J., Yin, J., Wu, S., Ge, M., Sun, W.-F., Zhao, J., Aisa, H. A., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.021 · Cited by 57
MyD88-dependent inflammasome activation and autophagy inhibition contributes to Ehrlichia-induced liver injury and toxic shock
Kader, M., Alaoui-El-Azher, M., Vorhauer, J., Kode, B. B., Wells, J. Z., Stolz, D. B., Michalopoulos, G. K., Wells, A. H., Scott, M. J., & Ismail, N. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006644 · Cited by 59
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
García-Martínez, E., Smith, M. M., Buqué, A., Aranda, F., de la Peña, F. A., Rubio, A. I., Cánovas, M. S., Conesa, M. A. V., Fucikova, J. P., Špíšek, R., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1433982 · Cited by 56
Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response
Fu, Y.-Z., Guo, Y., Zou, H.-M., Su, S., Wang, S., Yang, Q., Luo, M., & Wang, Y. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007691 · Cited by 60
Trial Watch—Immunostimulation with cytokines in cancer therapy
Vacchelli, E., Aranda, F., Bloy, N., Buqué, A., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1115942 · Cited by 60
OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion
Leisching, G. R., Cole, V., Ali, A. T., & Baker, B. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.029 · Cited by 55
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
Dulek, D. E., Fuhlbrigge, R. C., Tribble, A. C., Connelly, J. A., Loi, M. M., Chebib, H. E., Chandrakasan, S., Otto, W. R., Diorio, C. J., Keim, G. P., et al. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa098 · Cited by 56
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
Littera, R., Chessa, L., Deidda, S., Angioni, G., Campagna, M., Lai, S., Melis, M., Cipri, S., Firinu, D., Santus, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255608 · Cited by 57
Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
Ghasemzadeh, M., Ghasemzadeh, A., & Hosseini, E. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.09.004 · Cited by 55
Role of Globotriaosylceramide in Physiology and Pathology
Celi, A. B., Goldstein, J., Rosato‐Siri, M. V., & Pinto, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.813637 · Cited by 55
Interferon‑α and its effects on cancer cell apoptosis (Review)
Shi, W., Yao, X., Fu, Y., & Wang, Y. (2022) · Oncology Letters · doi:10.3892/ol.2022.13355 · Cited by 55
A review of the role of probiotics for the control of viral diseases in aquaculture
Chattaraj, S., Ganguly, A., Mandal, A., & MOHAPATRA, P. K. D. (2022) · Aquaculture International · doi:10.1007/s10499-022-00915-6 · Cited by 55
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Ayala, A. V., Hsu, C.-Y., Oles, R. E., Matsuo, K., Loomis, L. R., Buzun, E., Terrazas, M. C., Gerner, R. R., Lu, H.-H., Kim, S., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230063 · Cited by 57
Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1
Feng, K., Dèng, F., Hú, Z., Wáng, H., & Ning, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006563 · Cited by 55
Programmed cell death: the pathways to severe COVID-19?
Bader, S. M., Cooney, J. P., Pellegrini, M., & Doerflinger, M. (2022) · Biochemical Journal · doi:10.1042/bcj20210602 · Cited by 55
Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight
Banuet-Martínez, M., Yang, Y., Jafari, B., Kaur, A., Butt, Z. A., Chen, H., Yanushkevich, S. N., Moyles, I. R., Heffernan, J. M., & Korosec, C. S. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823000791 · Cited by 54
Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye
Smith, J. R., Todd, S., Ashander, L. M., Charitou, T., Ma, Y., Yeh, S., Crozier, I., Michael, M., Appukuttan, B., Williams, K. A., et al. (2017) · Translational Vision Science & Technology · doi:10.1167/tvst.6.4.12 · Cited by 54
Foxp3+ T reg cells control psoriasiform inflammation by restraining an IFN-I–driven CD8+ T cell response
Stockenhuber, K., Hegazy, A. N., West, N. R., Ilott, N. E., Stockenhuber, A., Bullers, S. J., Thornton, E. E., Arnold, I. C., Tucci, A., Waldmann, H., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172094 · Cited by 54
Multiple cytosolic DNA sensors bind plasmid DNA after transfection
Semenova, N., Bošnjak, M., Markelc, B., Žnidar, K., Čemažar, M., & Heller, L. C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz768 · Cited by 56
The role of cGAS/STING in intestinal immunity
Wottawa, F., Bordoni, D., Baran, N., Rosenstiel, P. C., & Aden, K. (2021) · European Journal of Immunology · doi:10.1002/eji.202048777 · Cited by 55
Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19
Guo, C., Wu, M., Huang, B., Zhao, R., Jin, L., Fu, B., Wang, P., Wang, D., Zheng, M., Fang, J., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01049-3 · Cited by 55
Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
Hazeldine, J., & Lord, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573662 · Cited by 55
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology
Park, J. K., Lee, E. B., Shin, K., Sung, Y., Kim, T., Kwon, S., Lee, M. S., Hong, S., Choi, B. Y., Lee, S., et al. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e95 · Cited by 53
Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Tan, P.-H., Ji, J., Hsing, C., Tan, R., & Ji, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214394 · Cited by 55
Mitochondrial DNA in cell death and inflammation
Heilig, R., Lee, J., & Tait, S. W. G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221525 · Cited by 56
Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins
Habiger, C., Jäger, G., Walter, M. J., Iftner, T., & Stubenrauch, F. (2015) · Journal of Virology · doi:10.1128/jvi.02137-15 · Cited by 53
FOSL1 Inhibits Type I Interferon Responses to Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions
Cai, B., Wu, J., Yu, X. H., Su, X., & Wang, R.-F. (2017) · mBio · doi:10.1128/mbio.02161-16 · Cited by 55
Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection
Macal, M., Jo, Y., Dallari, S., Chang, A. Y., Dai, J., Swaminathan, S., Wehrens, E. J., Fitzgerald-Bocarsly, P. A., & Zúñiga, E. I. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.020 · Cited by 53
Signaling Crosstalk Mechanisms That May Fine-Tune Pathogen-Responsive NFκB
Adelaja, A., & Hoffmann, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00433 · Cited by 53
Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons
Jafarzadeh, A., Nemati, M., Saha, B., Bansode, Y. D., & Jafarzadeh, S. (2020) · Viral Immunology · doi:10.1089/vim.2020.0076 · Cited by 57
Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS
Hertzog, J., Zhou, W., Fowler, G., Rigby, R. E., Bridgeman, A., Blest, H. T. W., Cursi, C., Chauveau, L., Davenne, T., Warner, B. E., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109217 · Cited by 54
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”
Azevedo‐Pereira, J. M., Pires, D., Calado, M. S., Mandal, M., Santos‐Costa, Q., & Anes, E. (2023) · Microorganisms · doi:10.3390/microorganisms11040853 · Cited by 52
The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics
Goh, J. Z. H., Hayr, L. D., Khromykh, A. A., & Slonchak, A. (2024) · Vaccines · doi:10.3390/vaccines12080865 · Cited by 52
Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer
Liu, X., Xi, X., Xu, S., Chu, H., Hu, P., Li, D., Zhang, B., Liu, H., Jiang, T., & Lu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1507501 · Cited by 52
cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice
Ruangkiattikul, N., Nerlich, A. G., Abdissa, K., Lienenklaus, S., Suwandi, A., Janze, N., Laarmann, K., Spanier, J., Kalinke, U., Weiß, S., et al. (2017) · Virulence · doi:10.1080/21505594.2017.1321191 · Cited by 52
Programmed Cell Death in the Pathogenesis of Influenza
Fujikura, D., & Miyazaki, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072065 · Cited by 54
Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes
Kim, J.-A., Seong, R.-K., Son, S. W., & Shin, O. S. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.038 · Cited by 52
Molecular Actors of Inflammation and Their Signaling Pathways: Mechanistic Insights from Zebrafish
Leiba, J., Özbilgiç, R., Hernández, L., Demou, M., Lutfalla, G., Yatime, L., & Chi, M. N. (2023) · Biology · doi:10.3390/biology12020153 · Cited by 53
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review
Gasparotto, M., Franco, C., Zanatta, E., Ghirardello, A., Zen, M., Iaccarino, L., Fabris, B., Doria, A., & Gatto, M. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103334 · Cited by 52
A 380-gene meta-signature of active tuberculosis compared with healthy controls
Blankley, S., Graham, C. M., Levin, J., Turner, J., Berry, M. P. R., Bloom, C. I., Xu, Z., Pascual, V., Banchereau, J., Chaussabel, D., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02121-2015 · Cited by 51
Self-citation
TNFα Impairs Rhabdoviral Clearance by Inhibiting the Host Autophagic Antiviral Response
Espín-Palazón, R., Martínez‐López, A., Roca, F. J., López‐Muñoz, A., Tyrkalska, S. D., Candel, S., García‐Moreno, D., Falcó, A., Meseguer, J., Estepa, A., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005699 · Cited by 51
Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection
Zhu, Q., Man, S. M., Karki, R., Malireddi, R. K. S., & Kanneganti, T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.096 · Cited by 51
Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia
Wedenoja, S., Yoshihara, M., Teder, H., Sariola, H. V., Gissler, M., Katayama, S., Wedenoja, J., Häkkinen, I. M. K., Ezer, S., Linder, N., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102872 · Cited by 51
Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics
Zhuang, S., & Torbett, B. E. (2021) · Viruses · doi:10.3390/v13030417 · Cited by 53
Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections
Hulme, K. D., Noye, E. C., Short, K. R., & Labzin, L. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.770066 · Cited by 52
Interferons: role in cancer therapy
Abdolvahab, M. H., Darvishi, B., Zarei, M., Majidzadeh-A, K., & Farahmand, L. (2020) · Immunotherapy · doi:10.2217/imt-2019-0217 · Cited by 50
Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production
Metwally, H., Tanaka, T., Li, S., Parajuli, G., Kang, S., Hanieh, H., Hashimoto, S., Chalise, J. P., Gemechu, Y., Standley, D. M., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay0574 · Cited by 51
Selective Autophagy Receptors in Antiviral Defense
Viret, C., Duclaux‐Loras, R., Nancey, S., Rozières, A., & Faure, M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.006 · Cited by 50
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
da Silva, R. P., Gonçalves, J. I. B., Zanin, R. F., Schuch, F. B., & de Souza, A. P. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657363 · Cited by 50
Mitochondria: the gatekeepers between metabolism and immunity
Trinchese, G., Cimmino, F., Catapano, A., Cavaliere, G., & Mollica, M. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1334006 · Cited by 57
Advances in the design and delivery of RNA vaccines for infectious diseases
Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115419 · Cited by 52
Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2
Ren, W., Fu, C.-L., Zhang, Y., Ju, X., Jiang, X., Song, J., Gong, M., Li, Z., Fan, W., Yao, J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403235121 · Cited by 53
Advances in the treatment of systemic lupus erythematosus
Scherlinger, M., Kolios, A. G. A., Kyttaris, V. C., & Tsokos, G. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01242-0 · Cited by 50
Type I IFN signaling facilitates the development of IL‐10‐producing effector CD8+ T cells during murine influenza virus infection
Jiang, L., Yao, S., Huang, S., Wright, J., Braciale, T. J., & Sun, J. (2016) · European Journal of Immunology · doi:10.1002/eji.201646548 · Cited by 52
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine
Raeven, R. H. M., Brummelman, J., Pennings, J. L. A., van der Maas, L., Tilstra, W., Helm, K., van Riet, E., Jiskoot, W., van Els, C. A. C. M., Han, W. G. H., et al. (2016) · Scientific Reports · doi:10.1038/srep38240 · Cited by 50
Porphyromonas gingivalis Promotes Unrestrained Type I Interferon Production by Dysregulating TAM Signaling via MYD88 Degradation
Mizraji, G., Nassar, M., Segev, H., Sharawi, H., Eli‐Berchoer, L., Capucha, T., Nir, T., Tabib, Y., Maimon, A., Dishon, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.047 · Cited by 51
Drivers of the immunopathogenesis in systemic lupus erythematosus
Rose, T., & Dörner, T. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.007 · Cited by 50
Deficiency of the AIM2–ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection
Yan, S., Shen, H., Lian, Q., Jin, W., Zhang, R., Lin, X., Gu, W., Sun, X., Meng, G., Tian, Z., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701177 · Cited by 50
IL‐1β activation in response to Staphylococcus aureus lung infection requires inflammasome‐dependent and independent mechanisms
Pires, S., & Parker, D. (2018) · European Journal of Immunology · doi:10.1002/eji.201847556 · Cited by 51
Metabolite-Sensing G Protein Coupled Receptor TGR5 Protects Host From Viral Infection Through Amplifying Type I Interferon Responses
Xiong, Q., Huang, H., Wang, N., Chen, R., Chen, N., Han, H., Wang, Q., Siwko, S. K., Liu, M., Qian, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02289 · Cited by 50
Sterile Lung Inflammation Induced by Silica Exacerbates Mycobacterium tuberculosis Infection via STING-Dependent Type 2 Immunity
Benmerzoug, S., Bounab, B., Rose, S., Gosset, D., Biet, F., Cochard, T., Xavier, A., Rouxel, N., Fauconnier, L., Horsnell, W. G. C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.110 · Cited by 50
A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses
Wang, Y., Song, Q., Huang, W., Lin, Y., Wang, X., Wang, C., Willard, B. B., Zhao, C., Jing, N., Holvey-Bates, E. G., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0386-6 · Cited by 52
The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas
Bhattacharya, B., Xiao, S., Chatterjee, S., Urbanowski, M. E., Ordoñez, A. A., Ihms, E. A., Agrahari, G., Lun, S., Berland, R., Pichugin, A. V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130319 · Cited by 50

Authors: McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
Affiliations: GlaxoSmithKline (United Kingdom) (GB)
National Institutes of Health (US)
National Institute for Medical Research (GB)
ORCID: Mayer-Barber, Katrin
Sher, Alan
Wack, Andreas
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2015-01-23
Volume: 15
Issue: 2
Pages: 87-103
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri3787
PMC: PMC7162685
OpenAlex: W2091129202
Cited by: 2,780
References: 238
Citations by year: 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44
FWCI: 15.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust (FC001126)
Francis Crick Institute (10206, 10126)
Cancer Research UK (FC001126)
National Institutes of Health
Medical Research Council (U117597139, U117565642)
National Institute of Allergy and Infectious Diseases
FP7 Ideas: European Research Council (294682)
Topics: Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Keywords: type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
MeSH terms: Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Type I interferons in infectious disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks